Frederick S. Kaplan, M.D.
Frederick S. Kaplan, M.D.
Isaac and Rose Nassau Professor of Orthopaedic Molecular Medicine in Orthopaedic Surgery
Department: Orthopaedic Surgery
Contact information
Hospital of the University of Pennsylvania
Department of Orthopaedic Surgery
Two Silverstein Pavilion
3400 Spruce Street
Philadelphia, PA 19104
Department of Orthopaedic Surgery
Two Silverstein Pavilion
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8726
Fax: 215-349-5928
Lab: 215-898-2330
Fax: 215-349-5928
Lab: 215-898-2330
Education:
B.A.
Johns Hopkins University, 1972.
M.D.
Johns Hopkins University, 1976.
Permanent linkB.A.
Johns Hopkins University, 1972.
M.D.
Johns Hopkins University, 1976.
Description of Other Expertise
Frederick S. Kaplan, M.D. is The Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the Division of Molecular Orthopaedic Medicine at the University of Pennsylvania School of Medicine. He is an alumnus of The Johns Hopkins University School of Medicine (1976), and was Chief Resident in Orthopaedic Surgery at The Hospital of The University of Pennsylvania and The Children’s Hospital of Philadelphia from 1980 to 1981.Kaplan was a Hartford Foundation Research Fellow in human genetics and molecular biology from 1989 to 1991 in the laboratory of his mentor and friend Dr. Michael Zasloff. This experience led to his exploration of the mechanisms for heterotopic bone formation and skeletal metamorphosis in several disabling childhood diseases.
In 1989, Kaplan, an orthopaedic surgeon, met a child with fibrodysplasia ossificans progressiva (FOP), a rare and disabling disorder in which the body forms a second skeleton of heterotopic bone. Motivated to know and do more, Kaplan began a pioneering second career on the molecular genetics of heterotopic ossification, work that led to the discovery of the FOP gene, to the description of the molecular pathophysiology of skeletal metamorphosis in humans, to the discovery of progressive osseous heteroplasia (another disorder of heterotopic ossification) and its causative gene and pathophysiology.
Along with his colleague Dr. Eileen Shore, Kaplan co-directs the only center in the world devoted entirely to this work, has organized the medical and scientific communities worldwide on these two rare conditions, and is recognized as the world’s leading expert on genetic disorders of heterotopic ossification and skeletal metamorphosis. In 1997, Kaplan was awarded the first endowed chair in the nation for orthopaedic molecular medicine.
The late Victor McKusick, the father of clinical genetics, described Kaplan as “one of the really outstanding orthopaedic researchers of his generation. His work with FOP and POH has been extraordinary and extends all the way from the patients to the bench and back again. The devotion of the families and the patients to him is testimony to the kind of human being he is.” Cited in 2006, as one of the15 people who make America great, Newsweek noted “the disease was so rare, nobody wanted to deal with it until he came along.”
Selected Publications
Kitterman JA, Strober JB, Kan L, Rocke DM, Cali A, Peeper J, Snow J, Delai PLR, Morhart R, Pignolo RJ, Shore EM, Kaplan FS. : Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol 2012.Kaplan J, Kaplan FS, Shore EM. : Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele–specific targeting. Gene Therapy 19:: 786-790, 2012.
Muglu JA, Garg A, Pandiarajan T, Shore EM, Kaplan FS, Uchil D, Dickson MJ.: Pregnancy in fibrodysplasia ossificans progressiva. Obstetric Medicine 5:: 35-38, 2012.
Liu JJ, Russell E, Zhang D, Kaplan FS, Pignolo RJ, Shore EM.: Paternally-inherited Gs-alpha mutation impairs adipogenesis and potentiates a lean phenotype in vivo. Stem Cells 30:: 1477-1485, 2012.
Hammond P, Suttie M, Hennekam RC, Allanson J, Shore EM, Kaplan FS.: The face signature of fibrodysplasia ossificans progressiva. Am J Med Genet 158A:: 1368-1380, 2012.
Chakkalakal SA, Zhang D, Culbert AL, Convente MR, Caron RJ, Wright AC, Maidment AD, Kaplan FS, Shore EM. : An Acvr1 Knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res 27:: 746-1756, 2012.
Kan L, Kitterman JA, Procissi D, Chakkalakal S, Peng C-Y, McGuire TL, Goldsby RE, Pignolo RJ, Shore EM, Kaplan FS, Kessler JA.: CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol 2012.
Zimmer J, Doelken SC, Horn D, Groppe JC, Shore EM, Kaplan FS, Seemann P.: Functional analysis of alleged NOGGIN Mutation G92E disproves its pathogenic relevance. PLoS One 7 ((4): e35062: ): 1-7, 2012.
Kaplan FS, Pignolo RJ, Shore EM.: Sensory nerves regulate the innate immune system and amplify heterotopic ossification. www.ifopa.org. July 21 2011.
Kaplan FS, Shore EM. : Derailing heterotopic ossification and RARing to go. Nat Med 17: 420-421, 2011.
